EVOLVE-IBERIA: Real-world evidence on vedolizumab and anti¿tumor necrosis factor-¿ as first- or second-line biologic treatment among patients with ulcerative colitis Francesc Casellas; Ana Gutiérrez-Casbas; Cristina Rodríguez; Javier P. Gisbert; Sabino Riestra; Claudia Herrera de Guise; Isabel Vera-Mendoza; M. Pilar Martínez-Montiel; Sónia Bernardo; Isabel Medeiros; Jesús Aparicio; Ignacio Tagarro; Teresa Letosa Abián; Carmen Montoto; J. Fernando Muñoz;

Antiphospholipid syndrome autoantibodies induction after treatment with anti-TNF alpha therapy in patients with IBD Virginia Robles-Alonso; Roser Solans; Ernesto Lastiri; Xavier Serra; Elena Céspedes-Martínez; Luís Mayorga; Claudia Herrera-deGuise; Francesc Casellas; Natalia Borruel;

98 - CONSULTA MÉDICA PARA PACIENTES CON COLITIS ULCEROSA: ELEMENTOS CLAVE PARA MEJORARLA Yago González-Lama; Elena Ricart; Ana Cabez; Pilar Fortes; Susana Gómez; Francesc Casellas;